Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company that focuses on the discovery, development and commercialization of treatment products for various medical conditions, including cancer, central nervous system disorders and sexual dysfunction. The company develops therapies that treat specific disease states. It sells its products under the Archexin, Serdaxin and Zoraxel brands. Archexin is used for the treatment of cancer in glioblastoma, ovary, stomach and pancreas. Its Serdaxin drug treats depression and mood disorders. Zoraxel is a centrally acting sexual dysfunction drug. The company leverages a proprietary nanomedicine research and multitarget aimed ligands platform that is an engine to discover anticancer drugs. Rexahn Pharmaceuticals also provides online information related to various medical disorders and drugs.